Ausgabe 1/2006
Inhalt (11 Artikel)
Who is WHO in myelodysplastic syndromes? Clinical implications of the WHO classification
Rami S. Komrokji, John M. Bennett
Lenalidomide (Revlimid, CC-5013) in myelodysplastic syndromes: Is it any good?
Mikkael A. Sekeres, Alan List
- Clinical Trials Report
Initial chemotherapy for chronic lymphocytic leukemia: What’s the standard of care?
Matt Kalaycio